Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
In this module, 9 hematology experts examine key studies in chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), presented at the 2022 Annual Meetings of the American Society of Clinical Oncology (ASCO), the European Hematology Association (EHA), Pan Pacific Lymphoma Conference, the European Society for Medical Oncology, and the Society of Hematologic Oncology (SOHO).
Please note that the slide thumbnails in this activity link to a highlights PowerPoint slideset covering the studies discussed by the faculty. This slideset may be downloaded by clicking on any of the thumbnails within the activity.
Clinical Care Options plans to measure the educational impact of this activity. A few questions will be asked twice: once at the beginning of the activity, and then once again after the discussion that informs the best choice. Your responses will be aggregated for analysis, and your specific responses will not be shared.
Before continuing with this educational activity, please take a moment to answer the following questions.
Contact Clinical Care Options
For customer support please email: customersupport@cealliance.com
Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.
